All Stories

  1. Artificial Intelligence for Prediction and Detection of Atrial Fibrillation from Sinus-Rhythm Electrocardiograms and Ambulatory Monitoring
  2. The Effects of GLP-1 Receptor Agonists on Retinal Microvascular Alterations
  3. Circulating miR-10b-5p as a Candidate Biomarker of Atrial Fibrillation Recurrence After Catheter Ablation: A Two-Phase Translational Study
  4. When the Apex Deceives: A Mobile Left Ventricular Mass After Myocardial Infarction
  5. Changes in NT-proBNP Levels According to SGLT2 Inhibitor Use in Patients Hospitalized for Acute Heart Failure Decompensation: A Prospective Cohort Study
  6. Prevalence and clinical significance of coronary arteries variations: A systematic review with meta-analysis
  7. Uric Acid, Homocysteine, and comorbidities in sarcoidosis
  8. Cardiac Syncope: An Underestimated Cause of Unexplained Syncope in the Elderly-Data from a Single High-Volume Syncope Unit
  9. Proprotein Convertase Subtilisin/Kexin Type 9 and Atherosclerotic Plaque Progression: A Systematic Review and Meta-Analysis of Intravascular Imaging Studies
  10. Artificial intelligence-enabled electrocardiography to predict impending episodes of ventricular tachycardia in individuals under continuous heart rhythm monitoring
  11. Eligibility for biological treatments in COPD patients experiencing a severe COPD exacerbation
  12. Single Versus Double Perclose Vascular Closure Device in Transfemoral Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis
  13. Correction: Anastasiou et al. MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients. Pharmaceuticals 2025, 18, 1908
  14. Unmasking Early Cardiac Fibrosis in Sarcoidosis: The Role of Plasma Aldosterone and Cardiac MRI
  15. Metformin Beyond Glycemic Control: Cardiovascular Protection and Diabetes Prevention
  16. MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients
  17. One Enzyme, Many Faces: The Expanding Role of DPP3 in Cardiovascular and Critical Care
  18. Prognostic Impact of Obesity, Cardiometabolic Risk Factors, and Vascular Function Markers on Outcomes in Ischemic Cardiomyopathy
  19. The Role of miRNAs in Chemotherapy-Induced Cardiotoxicity
  20. Artificial intelligence-enabled electrocardiographic ‘sex discrepancy’ as a predictor of atrial fibrillation recurrence: contextualising the findings of Park et al
  21. Trends in Utilization of Guideline-Directed Cardiorenal Protective Therapies for Chronic Kidney Disease in Patients with Cardiovascular Morbidity: Real World Data from Two Cross-Sectional Snapshots (HECMOS I and II)
  22. The Role of NLRP3 Inflammasome in Type 2 Diabetes Mellitus and Its Macrovascular Complications
  23. Lipoprotein (a) in the Development and Progression of Diabetic Retinopathy: A Systematic Review and Meta-Analysis
  24. Real-World Efficacy and Safety of the Subcutaneous Implantable Cardioverter Defibrillator: Insights from the GASP Registry
  25. Hybrid Pulmonary Rehabilitation Improves Cardiorespiratory Exercise Fitness in Formerly Hospitalised Long COVID Patients
  26. Endothelial Function and Matrix Metalloproteinase 9 (MMP9) in Women with Polycystic Ovary Syndrome (PCOS)
  27. Mitochondrial Dysfunction in the Development and Progression of Cardiometabolic Diseases: A Narrative Review
  28. Endothelial Function and Pro-Inflammatory Cytokines as Prognostic Markers in Acute Coronary Syndromes
  29. A Tale of Two Diseases: Decoding Aortic Stenosis and Cardiac Amyloidosis
  30. Gut Microbiota in Heart Failure—The Role of Inflammation
  31. Baseline right ventricular-to-pulmonary artery coupling and outcomes after transcatheter aortic valve replacement: a systematic review and meta-analysis
  32. The Impact of the COVID-19 Pandemic on Medical Training at the Greek National Health Service: A Cross-Sectional Study
  33. Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment
  34. Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies
  35. Septic Cardiomyopathy: Difficult Definition, Challenging Diagnosis, Unclear Treatment
  36. FGF21 Analogues in Patients With Metabolic Diseases: Systematic Review and Meta‐Analysis of Randomised Controlled Trials
  37. Unraveling MASLD Through the Use of Omics Technologies
  38. The Effect of Cardiometabolic Drugs on Non-Alcoholic Fatty Liver Disease (NAFLD), Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
  39. Endothelial Glycocalyx Damage and Arterial Thickness in Patients with Retinal Vein Occlusion (RVO)
  40. MicroRNAs as Prognostic Biomarkers for Atrial Fibrillation Recurrence After Catheter Ablation: Current Evidence and Future Directions
  41. Cancer Therapy-Related Cardiac Dysfunction: A Review of Current Trends in Epidemiology, Diagnosis, and Treatment
  42. Navigating Heart–Lung Interactions in Mechanical Ventilation: Pathophysiology, Diagnosis, and Advanced Management Strategies in Acute Respiratory Distress Syndrome and Beyond
  43. Tailored Therapies for Cardiogenic Shock in Hypertrophic Cardiomyopathy: Navigating Emerging Strategies
  44. Dulaglutide and Dapagliflozin Combination Concurrently Improves the Endothelial Glycocalyx and Vascular and Myocardial Function in Patients with T2DM and Albuminuria vs. DPP-4i
  45. Response to “Letter to Editor From Ishaq MU et al: ‘Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease’”
  46. Wearable Activity Trackers and Physical Activity Levels Among Members of the Athens Medical Association in Greece
  47. Multifaceted Impact of SGLT2 Inhibitors in Heart Failure Patients: Exploring Diverse Mechanisms of Action
  48. The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment
  49. Influenza Vaccination Practices and Perceptions Among Young Athletes: A Cross-Sectional Study in Greece
  50. Exercise Intolerance Is Associated with Cardiovascular Dysfunction in Long COVID-19 Syndrome
  51. Bridge to Life: Current Landscape of Temporary Mechanical Circulatory Support in Heart-Failure-Related Cardiogenic Shock
  52. The Association of Systemic Endothelial Dysfunction With Diffuse Diabetic Macular Edema
  53. The Impact of the COVID-19 Pandemic on Elite Swimmers and Water Polo Players: Lessons for the Future
  54. Impairment in Right Ventricular-Pulmonary Arterial Coupling in Overweight and Obesity
  55. Coronary Plaque Erosion: Epidemiology, Diagnosis, and Treatment
  56. Young and older patients with acute myocardial infarction: differences in risk factors and angiographic characteristics
  57. MicroRNAs in Atrial Fibrillation: Mechanisms, Vascular Implications, and Therapeutic Potential
  58. Unveiling the Role of Endothelial Dysfunction: A Possible Key to Enhancing Catheter Ablation Success in Atrial Fibrillation
  59. Silent Myocardial Ischemia: From Pathophysiology to Diagnosis and Treatment
  60. The Role of Ranolazine in Heart Failure-Current Concepts
  61. Diabetes Mellitus in Acute Coronary Syndrome
  62. New-Onset Atrial Fibrillation in the Critically Ill COVID-19 Patients Hospitalized in the Intensive Care Unit
  63. Impact of drinking water hardness on carotid atherosclerosis and arterial stiffness: Insights from the “Corinthia” study
  64. Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome
  65. Non-Alcoholic Fatty Liver Disease and Echocardiographic Parameters of Left Ventricular Diastolic Function: A Systematic Review and Meta-Analysis
  66. Attitudes and Practices Related to COVID-19 Vaccination with the Second Booster Dose among Members of Athens Medical Association: Results from a Cross-Sectional Study
  67. Novel Approaches to the Management of Diabetes Mellitus in Patients with Coronary Artery Disease
  68. Inflammasomes in Atherosclerosis—From Pathophysiology to Treatment
  69. Metabolic Syndrome and Atrial Fibrillation: Different Entities or Combined Disorders
  70. Exercise Effects on Left Ventricular Remodeling in Patients with Cardiometabolic Risk Factors
  71. Diffuse LAD and LV Thrombus as Possible Manifestation of Protein-S Deficiency in a Young Patient
  72. Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes
  73. The Role of Right Ventriculo–Arterial Coupling in Symptoms Presentation of Patients with Hypertrophic Cardiomyopathy
  74. Correlation of Clinical Outcomes with the Prominent Indication of Transcatheter Paravalvular Leak Closure: A Multicenter Experience
  75. Exercise Effects on Left Ventricular Remodeling in Patients With Cardiometabolic Risk Factors
  76. The Role of Right Ventriculo-Arterial Coupling in Symptoms Presentation of Patients With Hypertrophic Cardiomyopathy
  77. Midterm Outcomes in Patients With Aortic Stenosis Treated With Contemporary Balloon‐Expandable and Self‐Expanding Valves: Does Valve Size Have an Impact on Outcome?
  78. The Role of Macrophages in Atherosclerosis: Pathophysiologic Mechanisms and Treatment Considerations
  79. Lipoprotein(a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis
  80. The Role of Rehabilitation in Arterial Function Properties of Convalescent COVID-19 Patients
  81. Impact of Evolution of Self-Expandable Aortic Valve Design: Peri-Operative and Short-Term Outcomes
  82. Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure
  83. Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment
  84. Lipoprotein (a) levels and Abdominal Aortic Aneurysm. A Systematic Review and Meta-analysis
  85. The Anti-Inflammatory Effect of Novel Antidiabetic Agents
  86. Interleukin-1 in Coronary Artery Disease
  87. Vaccination Against SARS-CoV-2 Protects from COVID-19-induced Endothelial Dysfunction
  88. Evaluation of the Perceptions, Attitudes and Practices among Greek Non-Professional Athletes Visiting a Public Hospital during March 2022, towards COVID-19 Vaccination and Its Consequences on Sports Training and Sports Activity
  89. The effect of stress management in patients post-acute myocardial infarction
  90. Impaired left ventricular deformation and ventricular-arterial coupling in post-COVID-19: association with autonomic dysregulation
  91. COVID-19, Endothelium and the Cardiometabolic Patient: A Possible Role for Capillary Leak Syndrome
  92. Granulocyte Colony-Stimulating Factor Ameliorates Endothelial Activation and Thrombotic Diathesis Biomarkers in a Murine Model of Hind Limb Ischemia
  93. Percutaneous Treatment Approaches in Atrial Fibrillation: Current Landscape and Future Perspectives
  94. Pericoronary fat attenuation index—a new imaging biomarker and its diagnostic and prognostic utility: a systematic review and meta-analysis
  95. Association of Growth Differentiation Factor 15 with Arterial Stiffness and Endothelial Function in Subpopulations of Patients with Coronary Artery Disease: A Proof-of-Concept Study
  96. Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques
  97. The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis
  98. The Role of Cell-derived Microparticles in Cardiovascular Diseases: Current Concepts
  99. Increased Influenza Vaccination Coverage among Members of the Athens Medical Association Amidst COVID-19 Pandemic
  100. Expression of Tissue microRNAs in Ascending Aortic Aneurysms and Dissections
  101. Evaluation of Knowledge, Attitudes and Practices Related to Self-Testing Procedure against COVID-19 among Greek Students: A Pilot Study
  102. Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches
  103. The association of diabetes mellitus with carotid atherosclerosis and arterial stiffness in the Corinthia study
  104. The Association of Physical Activity with Arterial Stiffness and Inflammation: Insight from the “Corinthia” Study
  105. A case report of left ventricular thrombus formation following aggressive decongestion treatment
  106. Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?
  107. Association of arterial stiffness with functional parameters in patients with systolic heart failure: Data from the Corinthia study
  108. Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics
  109. Inflammation in Coronary Microvascular Dysfunction
  110. MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the Art
  111. Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19
  112. Sex Differences in Clinical Outcomes of Patients with Stable Coronary Artery Disease after Percutaneous Coronary Intervention
  113. MicroRNAs in the Management of Heart Failure
  114. Risk factors profile of young and older patients with myocardial infarction
  115. Inflammatory Mechanisms Contributing to Endothelial Dysfunction
  116. Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives
  117. The Hellenic Journal of Cardiology: a 64-year voyage of discovery from the cradle of European civilization to the world
  118. Regulation of Long Non-Coding RNAs by Statins in Atherosclerosis
  119. The Effect of DPP-4i on Endothelial Function and Arterial Stiffness in Patients with Type 2 Diabetes: A Systematic Review of Randomized Placebo-controlled Trials
  120. Novel Antidiabetic Agents: Cardiovascular and Safety Outcomes
  121. Association of Soluble Suppression of Tumorigenesis-2 (ST2) with Endothelial Function in Patients with Ischemic Heart Failure
  122. Pro-inflammatory Cytokines in Acute Coronary Syndromes
  123. Arterial stiffness and microvascular disease in type 2 diabetes
  124. “The role of intracoronary administration of stem cells on myocardial reperfusion injury”
  125. Hospital attendance and admission trends for cardiac diseases during the COVID-19 outbreak and lockdown in Greece
  126. High-Intensity Endurance and Strength Training in Water Polo Olympic Team Players: Impact on Arterial Wall Properties
  127. Antithrombotic Treatment in Diabetes Mellitus: A Review of the Literature about Antiplatelet and Anticoagulation Strategies Used for Diabetic Patients in Primary and Secondary Prevention
  128. Antithrombotic Therapy in Carotid Artery Disease
  129. Current Antithrombotic Therapy: Beyond Coronary Artery Disease
  130. Proposed algorithm for return to sports in competitive athletes who have suffered COVID-19
  131. Development of a risk score for early saphenous vein graft failure: An individual patient data meta-analysis
  132. A reappraisal of the role of transthoracic ultrasound in the era of COVID-19. Patient evaluation through new windows
  133. Relationship between whole grain consumption and arterial stiffness. Results of the Corinthia cross-sectional study
  134. Acute Coronary Syndrome with Non-ruptured Plaques (NONRUPLA): Novel Ideas and Perspectives
  135. Cardiovascular disease and socioeconomic status
  136. Alirocumab and evolocumab: an indirect comparison of cardiovascular benefits
  137. Endothelial dysfunction and impaired arterial wall properties in patients with retinal vein occlusion
  138. MicroRNAs in Cardiovascular Disease
  139. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
  140. Coronary Artery Disease and Endothelial Dysfunction: Novel Diagnostic and Therapeutic Approaches
  141. Mir-335-5p as a Potential Regulator of LRP1 Expression in Abdominal Aortic Aneurysm
  142. Acute exposure to diesel affects inflammation and vascular function
  143. Aortic regurgitation in competitive athletes: The role of multimodality imaging for clinical decision-making
  144. Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy
  145. The aetiology of death for marathon runner Phidippides?
  146. Reply: Possible Effect of Alcohol Consumption on Aortic Dilatation by Inducing the Renin–Angiotensin–Aldosterone System
  147. Aortic stiffening is associated with increased left ventricular mass in women but not in men
  148. Breakfast association with arterial stiffness and carotid atherosclerotic burden. Insights from the ‘Corinthia’ study
  149. Galectin-3 and Arterial Stiffness in Patients with Heart Failure: A Pilot Study
  150. The influence of resting heart rate on pulse wave velocity measurement is mediated by blood pressure and depends on aortic stiffness levels: insights from the Corinthia study
  151. Pseudoexfoliative Glaucoma, Endothelial Dysfunction, and Arterial Stiffness
  152. Alcohol Consumption and Aortic Root Dilatation: Insights from the Corinthia Study
  153. Arterial stiffness and subclinical aortic damage of reclassified subjects as stage 1 hypertension according to the new 2017 ACC/AHA blood pressure guidelines
  154. Atrial Fibrillation: Biomarkers Determining Prognosis
  155. Biomarkers Determining Prognosis of Atrial Fibrillation Ablation
  156. Biomarkers in Atrial Fibrillation and Heart Failure
  157. MicroRNAs in Atrial Fibrillation
  158. Galectin-3
  159. Cardiovascular effects of electronic cigarettes: A systematic review and meta-analysis
  160. The effect of diet, lifestyle and psychological factors in the prognosis of ischemic heart failure
  161. Hyponatremia in patients with atrial fibrillation and heart failure: The difficult triangle
  162. Vitamin D: A cardiovascular risk biomarker or a treatment target?
  163. Cancer Therapeutics-Related Cardiovascular Complications. Mechanisms, Diagnosis and Treatment
  164. Heart failure a cluster of comorbidities or a unique entity?
  165. Associations between Adiponectin Gene Variability, Proinflammatory and Angiogenetic Markers: Implications for Microvascular Disease Development in Type 2 Diabetes Mellitus?
  166. The impact of sedentary behavior patterns on carotid atherosclerotic burden: Implications from the Corinthia epidemiological study
  167. The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
  168. Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis
  169. The association among biomarkers of renal and heart function in patients with heart failure: the role of NGAL
  170. Coronary Microcirculation and the No-reflow Phenomenon
  171. Myocardial performance versus exercise tolerance. What matters the most in patients with heart failure?
  172. The Impact of Omega 3 Fatty Acids in Atherosclerosis and Arterial Stiffness: An Overview of their Actions
  173. Polymorphism Gln27Glu of β2 Adrenergic Receptors in Patients with Ischaemic Cardiomyopath
  174. Inflammation: A pathogenetic mechanism or a mediator, linking risk factors and cardiovascular disease?
  175. Non-natriuretic peptide biomarkers in heart failure with preserved and reduced ejection fraction
  176. Effects of omega-3 polyunsaturated fatty acids on fibrosis, endothelial function and myocardial performance, in ischemic heart failure patients
  177. Circulating microparticles: Simply a research tool or a candidate clinical meaningful biomarker?
  178. Local Low Shear Stress and Endothelial Dysfunction in Patients With Nonobstructive Coronary Atherosclerosis
  179. Impact of “high” implantation on functionality of self-expandable bioprosthesis during the short- and long-term outcome of patients who undergo transcatheter aortic valve implantation: Is high implantation beneficial?
  180. Anti-inflammatory agents in peripheral arterial disease
  181. Coronary versus carotid artery plaques. Similarities and differences regarding biomarkers morphology and prognosis
  182. Editorial overview: Cardiovascular and renal: Novel therapies in peripheral artery disease
  183. Peripheral artery disease: a micro-RNA-related condition?
  184. Predictors of switching from nonsteroidal anti-inflammatory drugs to corticosteroids in patients with acute pericarditis and impact on clinical outcome
  185. Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance
  186. Echocardiography for the management of patients with biventricular pacing: Possible roles in cardiac resynchronization therapy implementation
  187. Statins and Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis
  188. Statins in Aortic Disease
  189. Prognostic significance of arterial stiffness and osteoprotegerin in patients with stable coronary artery disease
  190. 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomographic Imaging Detects Aortic Wall Inflammation in Patients With Repaired Coarctation of Aorta
  191. Flow-Mediated Dilation of Brachial Artery as a Screening Tool for Anthracycline-Induced Cardiotoxicity
  192. Statins and inflammation in cardiovascular disease
  193. Statins and left ventricular function
  194. Statins in Stable Angina Pectoris
  195. Statins in Aortic Stenosis
  196. Long-term endothelial dysfunction after trans-radial catheterization: A meta-analytic approach
  197. Western Dietary Pattern Is Associated With Severe Coronary Artery Disease
  198. Redox State in Atrial Fibrillation Pathogenesis and Relevant Therapeutic Approaches
  199. Macrovascular function indices for the prediction of diabetic retinopathy development in patients with type 2 diabetes
  200. Antiplatelet and Anticoagulation Therapy in Structural Heart Disease Interventions Beyond TAVI
  201. Genetics in the Clinical Decision of Antiplatelet Treatment
  202. Beneficial Effects of Sildenafil on Tissue Perfusion and Inflammation in a Murine Model of Limb Ischemia and Atherosclerosis
  203. Impact of balloon aortic valvuloplasty on transcatheter aortic valve implantation with self-expandable valve
  204. Genotyping, Platelet Activation, and Cardiovascular Outcome in Patients after Percutaneous Coronary Intervention: Two Pieces of the Puzzle of Clopidogrel Resistance
  205. Prognostic implications of epicardial fat volume quantification in acute pericarditis
  206. Established and novel treatment options in acute myocarditis, with or without heart failure
  207. Correlation of CoreValve implantation ‘true cover index’ with short and mid-term aortic regurgitation: A novel index
  208. The impact of T786C and G894T polymorphisms of eNOS on vascular endothelial growth factor serum levels in type 2 diabetes patients
  209. Effects of transradial coronary catheterization on systemic and local vascular endothelial function and inflammatory process
  210. Usefulness of C-Reactive Protein as a Predictor of Contrast-Induced Nephropathy After Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction and Presentation of a New Risk Score (Athens CIN Score)
  211. Novel risk factors’ hunting. Lessons from the study of older olds
  212. The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: A systematic review and meta-analysis
  213. The prognostic role of C-reactive protein after myocardial infarction in patients with normal or mildly impaired left ventricle systolic function
  214. Dual or Single Antiplatelet Therapy After Transcatheter Aortic Valve Implantation? A Systematic Review and Meta-Analysis
  215. Targeting percutaneous cardiovascular interventions at all who will benefit the most: The reality of the Eastern European countries
  216. The impact of dietary flavonoid supplementation on smoking-induced inflammatory process and fibrinolytic impairment
  217. Duration of Dual Antiplatelet Therapy after Coronary Stenting
  218. Acute effects of different types of aerobic exercise on endothelial function and arterial stiffness
  219. Characterization of vascular phenotype in patients with coronary artery ectasia: The role of endothelial dysfunction
  220. The Interaction Between Gender and Diabetes Mellitus in the Coronary Heart Disease Risk
  221. Antiplatelet Therapy in Acute Coronary Syndromes. Evidence Based Medicine
  222. Incessant pericarditis following dual-chamber cardioverter defibrillation device implantation
  223. Environment and cardiovascular disease: rationale of the Corinthia study
  224. Do we really need novel echocardiographic modalities to confirm the superiority of the intact His-Purkinje conduction system over pacing modes?
  225. Impact of C34T P2Y12 ADP receptor polymorphism and smoking status on cardiovascular outcome in coronary artery disease patients receiving clopidogrel
  226. Impairment of arterial elastic properties and elevated circulating levels of transforming growth factor-beta in subjects with repaired coarctation of aorta
  227. Basic Mechanisms in Atherosclerosis: The Role of Calcium
  228. Inflammatory cytokines in atherosclerosis: current therapeutic approaches
  229. The Acute Impact of Different Types of Aerobic Exercise on Arterial Wave Reflections and Inflammation
  230. Atherogenesis and hyperlipidemia a not straightforward association: We really need a novel biomarker?
  231. Different Prognostic Significance of Cardiac Troponin at Presentation and Peak Cardiac Troponin in Patients with Non-ST Segment Elevation Myocardial Infarction
  232. Impact of Laparoscopic Sleeve Gastrectomy on Weight Loss and Associated Comorbidities in Adolescents and Young Adults
  233. Real-time three-dimensional echocardiography: never before clinical efficacy looked so picturesque
  234. Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy
  235. Arterial Wall Elastic Properties and Endothelial Dysfunction in the Diabetic Foot Syndrome in Patients With Type 2 Diabetes
  236. The role of microRNAs in coronary artery disease: From pathophysiology to diagnosis and treatment
  237. Vascular function and ocular involvement in sarcoidosis
  238. Genetic testing and antiplatelet treatment: Still way to go?
  239. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients
  240. Flow-mediated dilation: Is it just a research tool or a useful biomarker for cardiovascular prognosis
  241. An unusual case of a three coronary artery spasm
  242. Role of Endothelial Dysfunction and Arterial Stiffness in the Development of Diabetic Retinopathy: Figure 1
  243. Reply: Long term impact of CPAP on myocardial function in OSA. Always measurable cardiac index?
  244. Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches
  245. Impact of C34T P2Y12 genotype on endothelial function and arterial stiffness in patients after percutaneous coronary intervention receiving clopidogrel
  246. Impact of folic acid administration in homocysteine levels, inflammation and in atherosclerotic plaque area in apoE deficient mice
  247. Oxidative Stress and Early Atherosclerosis: Novel Antioxidant Treatment
  248. High platelet reactivity is associated with vascular function in patients after percutaneous coronary intervention receiving clopidogrel
  249. Segmental myocardial hypokinesis and hypertrophy as initial echocardiographic presentation of myocarditis
  250. Combined effects of smoking and interleukin-6 and C-reactive protein genetic variants on endothelial function, inflammation, thrombosis and incidence of coronary artery disease
  251. Vascular effects of circulating CD4-T cells in patients with unstable angina
  252. Pro-Inflammatory Interleukin Genotypes Potentiate Early and Advanced Atherosclerosis Differently
  253. Impact of continuous positive airway pressure treatment on myocardial performance in patients with obstructive sleep apnea. A conventional and tissue Doppler echocardiographic study
  254. Cystatin-C serum levels and vascular function in heart failure
  255. Divergent effects of folic acid administration on inflammatory status and cholesterol levels in apoE deficient mice
  256. The Natural History of Multifocal Atrial Rhythms in Elderly Outpatients: Insights from the “Ikaria Study”
  257. The impact of AMPD1 gene polymorphism on vascular function and inflammation in patients with coronary artery disease
  258. Novel biomarkers in heart failure: usefulness in clinical practice
  259. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome
  260. Statins in heart failure—With preserved and reduced ejection fraction. An update
  261. Vitamin D serum levels are associated with cardiovascular outcome in coronary artery disease
  262. Favorable Effects of Concord Grape Juice on Endothelial Function and Arterial Stiffness in Healthy Smokers
  263. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease
  264. The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel
  265. Long-Term Fish Intake Preserves Kidney Function in Elderly Individuals: The Ikaria Study
  266. MicroRNAs: Novel Diagnostic and Prognostic Biomarkers in Atherosclerosis
  267. Novel Biomarkers Assessing Endothelial Dysfunction: Role of microRNAs
  268. MicroRNAs: Biomarkers for Cardiovascular Disease in Patients with Diabetes Mellitus
  269. Diagnostic and Therapeutic Potentials of microRNAs in Heart Failure
  270. MicroRNAs in the Diagnosis and Treatment of Unstable Angina
  271. MicroRNAs in Cardiovascular Therapeutics
  272. Effects of omega-3 fatty acids on endothelial function, arterial wall properties, inflammatory and fibrinolytic status in smokers: A cross over study
  273. Flavonoids in Atherosclerosis: An Overview of Their Mechanisms of Action
  274. Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure
  275. Consumption of a boiled Greek type of coffee is associated with improved endothelial function: The Ikaria Study
  276. Genetic Predisposition to Left Ventricular Hypertrophy and the Potential Involvement of Cystatin-C in Untreated Hypertension
  277. Aortic elastic properties and cognitive function in elderly individuals: The Ikaria Study
  278. Low Total Testosterone Levels are Associated With the Metabolic Syndrome in Elderly Men: The Role of Body Weight, Lipids, Insulin Resistance, and Inflammation; The Ikaria Study
  279. Aortic artery distensibility shows inverse correlation with heart rate variability in elderly non-hypertensive, cardiovascular disease-free individuals: the Ikaria Study
  280. Comparable effects of pioglitazone and perindopril on circulating endothelial progenitor cells, inflammatory process and oxidative stress in patients with diabetes mellitus
  281. Adiponectin and Cardiovascular Disease: Mechanisms and New Therapeutic Approaches
  282. Genetic polymorphism M235T of angiotensinogen: Effects on endothelial function and arterial stiffness in hypertensives
  283. Novel Biomarkers Assessing the Calcium Deposition in Coronary Artery Disease
  284. Asymmetric dimethylarginine (ADMA): Is really a biomarker for cardiovascular prognosis?
  285. Cross-sectional relationship of a Mediterranean type diet to diastolic heart function in chronic heart failure patients
  286. Anti-tumor necrosis factor alpha treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis
  287. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population
  288. Gender variation of exercise-induced anti-arrhythmic protection: the Ikaria Study
  289. Association of Sarcoidosis With Endothelial Function, Arterial Wall Properties, and Biomarkers of Inflammation
  290. The association between glaucoma, vascular function and inflammatory process